NYSE$VTR

Ventas Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Ventas's Q1 2023 performance was driven by SHOP and medical office buildings, emphasizing financial strength and flexibility.

Ventas reported solid first-quarter results, driven by SHOP and medical office buildings growth. The company reaffirmed its Normalized FFO guidance for the full year and remains focused on financial strength and flexibility. Ventas completed its plan to take ownership of the Santerre Portfolio and continues to focus on maximizing the value of the assets.

  • Ventas's Q1 results underscore strong momentum across the business.
  • SHOP led performance with outstanding top- and bottom-line growth.
  • Ventas is focused on financial strength and flexibility.
  • The company reaffirmed Normalized FFO guidance for the full year.

Headline financials

Total Revenue

$1.08B

Previous: $1.02B+5.9%
EPS (adj)

$0.74

Previous: $0.79-6.3%
Capital Expenditures

-$182M

Previous: -$799M+77.3%
Free Cash Flow

-$163M

Previous: -$759M+78.5%
Net Income

$18.9M

Previous: $40.6M-53.4%
Operating Income

$139M

Previous: $110M+26.5%
Gross Profit

$476M

Previous: $474M+0.4%
Cash & Equivalents

$145M

Previous: $150M-2.8%
Total Assets

$24B

Previous: $25B-3.8%
Stock-Based Comp

$15.1M

Previous: $15.8M-4.7%

Revenue & EPS history

Ventas · Revenue · Quarterly

$1.08B

Q1 2023+5.9%vs Q1 2022
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Ventas · $725M total across 4 segments · Q1 2023

  • Resident fees and services
    $705M+8.3%
  • Income from loans and investments
    $13.6M+38.0%
  • Third-party capital management revenues
    $4.18M
  • Interest and other income
    $1.74M+225.2%

Forward guidance

Ventas reaffirmed its previous full year guidance for Normalized FFO. The company also reaffirmed its guidance for net income attributable to common stockholders and Nareit FFO before the impact of purchase accounting adjustments and other GAAP impacts.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

+0.6%

Avg return

Earnings day

+1.1%

Avg return

5 days after

+2.3%

Avg return

30 days after

58%

42 / 73 earnings

Positive

+13.9%

Q3 2020

Best reaction

-10.8%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+3.9%+1.7%
Q4 2025+3.4%+7.3%+6.3%
Q3 2025+6.8%+7.4%+15.5%
Q2 2025+0.5%+2.0%+1.3%
Q1 2025-6.5%-6.1%-8.3%
Q4 2024+8.3%+11.4%+11.6%
Q3 2024-0.8%-2.5%-3.0%
Q2 2024+3.6%+5.0%+14.1%
Q1 2024+4.4%+6.3%+13.5%
Q4 2023-0.6%-1.6%-4.5%
Q3 2023+3.0%+2.3%+9.3%
Q2 2023-7.3%-6.2%-11.1%
Q1 2023-2.1%-2.8%-3.1%
Q4 2022-1.7%-2.0%-13.9%
Q3 2022+5.7%+13.0%+23.7%
Q2 2022-5.1%-1.9%-8.2%
Q1 2022-1.4%-8.9%-2.7%
Q4 2021+1.0%+0.9%+13.4%
Q3 2021-0.5%+3.7%-10.7%
Q2 2021-4.3%-5.1%-6.1%
Q1 2021+1.7%-3.4%+5.1%
Q4 2020+3.5%+7.9%+7.6%
Q3 2020+13.9%+17.8%+20.3%
Q2 2020+7.8%+4.0%+12.8%
Q1 2020+7.2%-1.1%+59.8%
Q4 2019+6.5%+1.1%-63.4%
Q3 2019-10.8%-10.4%-20.8%
Q2 2019+0.1%-0.3%+6.7%
Q1 2019+0.7%+2.8%+10.9%
Q4 2018-1.1%-0.4%-3.8%
Q3 2018+0.6%+2.0%+8.0%
Q2 2018-3.3%-0.9%+2.4%
Q1 2018+8.3%+10.3%+13.0%
Q4 2017-0.9%-2.6%-2.4%
Q3 2017+3.5%+3.2%+5.9%
Q2 2017-0.1%-2.1%+0.7%
Q1 2017-0.2%-2.1%+3.8%
Q4 2016+1.6%-0.2%-2.1%
Q3 2016+2.0%-4.8%-9.3%
Q2 2016+2.7%-1.1%-3.2%
Q1 2016+0.6%
Q4 2015+2.1%
Q3 2015-5.7%
Q2 2015+3.8%
Q1 2015-1.0%
Q4 2014-0.7%
Q3 2014-0.6%
Q2 2014-0.3%
Q1 2014+2.2%
Q4 2013-1.9%
Q3 2013+0.9%
Q2 2013-1.1%
Q1 2013+0.5%
Q4 2012+2.3%
Q3 2012+0.4%
Q2 2012+2.2%
Q1 2012+0.1%
Q4 2011+1.1%
Q3 2011+0.9%
Q2 2011-9.3%
Q1 2011-1.7%
Q4 2010-6.2%
Q3 2010-0.5%
Q2 2010+4.0%
Q1 2009-0.8%
Q1 2010-1.6%
Q4 2007+0.2%
Q4 2009+0.2%
Q3 2008-2.1%
Q3 2009-2.1%
Q2 2008+1.7%
Q2 2009+1.7%
Q4 2008+1.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro